Skip to main content
Caplight Logo









Aphios Corporation

Aphios Corporation

Private
North Reading, MassachusettsHealthcare & Life Scienceshttps://aphios.com

Last Round

Grant

Oct 23, 2025

Est. Valuation

$70.09M

Total Funding Raised

$8.78M

Company Overview

Aphios Corporation operates in Healthcare & Life Sciences and is based in North Reading, Massachusetts. Its latest recorded funding round was a Grant round in October 2025.

Aphios Corporation is a biotechnology company that develops enabling technology platforms and therapeutics for the treatment of cancer, infectious diseases, and central nervous system disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment, Clean Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts, Revenue Share

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Aphios Corporation Comparables

Compare Aphios Corporation with similar companies based on industry and business-model similarity.

Aphios Corporation comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
StaniPharm
77%
Nanoform Finland Oyj
74%
Crystec Pharma
72%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Aphios Corporation Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 23, 2025
GrantDec 11, 2024
GrantSep 20, 2024
GrantSep 6, 2023
GrantMar 3, 2023
Crowdfunding
Jul 31, 2022
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Aphios Corporation Investors

Notable investors and investment history

Book a demo to see all 9 investors

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 20, 2026

    Monthly visitors increased 49% MoM.

  • Jan 8, 2026

    Monthly visitors increased 114% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • hiresOct 6, 2026

    Aphios appoints Dr. Juliette M. Tuakli, MD, MPH, to its board of directors, effective Oct 5th '26 in Massachusetts, as the biotechnology company advances its therapeutic pipeline and strategic partnerships.

Book a demo to see all news

For institutional investors. Book with your work email.

Aphios Corporation Filings

Explore SEC and related filing metadata, where available.

Aphios Corporation filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Aphios Corporation's valuation, stock price, and market status.

Is Aphios Corporation a public or private company?

Aphios Corporation is a private company.

What is the current stock price of Aphios Corporation?

Aphios Corporation is a private company, so its shares have no public market price. Caplight tracks Aphios Corporation's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Aphios Corporation worth (valuation)?

Aphios Corporation's valuation is estimated at $70.1M based on funding round data.

Can I buy Aphios Corporation stock?

Aphios Corporation shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Aphios Corporation's last funding round?

Aphios Corporation's most recent funding round was Grant on October 23, 2025.

Who are the main investors in Aphios Corporation?

Key investors in Aphios Corporation include National Institute of Allergy and Infectious Diseases, NIH RADx, National Center for Complementary and Integrative Health, National Institute on Aging.

Will Aphios Corporation IPO soon?

No public IPO plans have been announced for Aphios Corporation.

How can I track Aphios Corporation secondary market activity?

Caplight tracks bids, offers, and trades in Aphios Corporation's shares on secondary markets.

Firmographic Details

HeadquartersNorth Reading, Massachusetts
Employee Range14
Year Founded1993
Last FundingOct 23, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?